J. Lim

Multi-omics limitations in patient-derived cancer organoids: molecular origins and strategies for mitigation

Patient-derived organoids (PDOs) are widely used platforms for cancer modeling and precision oncology because they preserve patient-specific genetic backgrounds, recapitulate aspects of native tissue architecture, and allow long-term expansion, repeated functional interrogation, and drug screening. Accordingly, multi-o...